PBOA First Annual Meeting & Conference

This event is open exclusively to PBOA-member companies! If you’re a PBOA member and are interested in attending, e-mail us at conference@pharma-bio.org for more information!

Get the insider’s view on the regulatory, legislative and market trends driving the biopharmaceutical CDMO industry:

• How will CDMOs be impacted by the new Congress and administration?
• What are the implications of FDA’s inspectorate overhaul and mutual recognition with EMA?
• What opportunities and threats are CDMOs facing from overall industry trends?
• How will CDMOs be affected by ongoing regulatory initiatives, like FDA’s Quality Metrics initiative?
• What’s the latest in facility design and manufacturing technology, and how does it impact the CDMO sector?
• How can CMOs work better with innovators in the highly potent API space?

These and other issues will be addressed by leading industry experts and policy organizations with unique insights and impacts on the CMO/CDMO industry including FDA, BCG, IPS, BioPlan Associates, PharmSource, BGR Group, Lachman Associates, SafeBridge Consultants, RBC, and more!

This event is geared toward executive, quality, regulatory and operations executives and will include a networking reception and dinner.